What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001035674
Total reported value
$2.6B
$2.6B
9 檔
104.8%
At the close of Q1 2026, Paulson & Co. Inc. disclosed equity holdings valued at approximately $2.6B, spread across 9 reported holdings.
In Q1 2026, Paulson & Co. Inc. displayed an active expansion posture, initiating 1 new positions and adding to 2 existing holdings, outstripping position reductions.
In terms of portfolio concentration, the top 5 core holdings (including PPTA, MDGL, AAMI) accounted for 104.8% of total reported equity market value during Q1 2026.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | PPTA | Perpetua Resources CORP | Stock-Other | 29.23% | -3.16% | — | |
| 2 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 23.42% | +4.52% | -18.47% | |
| 3 | AAMI | Acadian Asset Management Inc | Stock-Other | 13.54% | +2.69% | — | |
| 4 | BHC | Bausch Health Cos Inc | Stock-Healthcare | 12.71% | +1.31% | — | |
| 5 | NG | Novagold Resources Inc | Stock-Other | 7.86% | -1.55% | — | |
| 6 | THM | Intl Tower Hill Mines LTD | Stock-Other | 7.36% | +0.71% | +41.76% | |
| 7 | AEM | Agnico Eagle Mines LTD | Stock-Materials | 5.11% | -5.11% | EXIT | |
| 8 | THRY | Thryv Holdings Inc | Stock-Other | 0.74% | +0.55% | +94.24% | |
| 9 | AM6 | Amicus Therapeutics Inc | Stock-Other | 0.02% | -0.02% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | PPTA | Perpetua Resources CORP | +5.2% | — | Unchanged |
| 2 | THM | Intl Tower Hill Mines LTD | +3.4% | +41.76% | Add |
| 3 | AAMI | Acadian Asset Management Inc | +2.4% | — | Unchanged |
| 4 | AEM | Agnico Eagle Mines LTD | +1% | — | Unchanged |
| 5 | NG | Novagold Resources Inc | +0.1% | — | Unchanged |
| 6 | THRY | Thryv Holdings Inc | -0.1% | +94.24% | Add |
| 7 | BHC | Bausch Health Cos Inc | -2.9% | — | Unchanged |
| 8 | MDGL | Madrigal Pharmaceuticals Inc | -7.1% | -18.47% | Trim |
| 9 | SOLS | Solstice Adv Materials Inc | — | EXIT | Sold out |
| 10 | AM6 | Amicus Therapeutics Inc | — | NEW | New buy |
According to official SEC Form 13F filings, Paulson & Co. Inc. reported a total U.S. public equity portfolio value of $2.6B across 9 disclosed positions in Q1 2026.
During Q1 2026, Paulson & Co. Inc.'s top holdings by market value included PPTA (29.2%)、MDGL (23.4%)、AAMI (13.5%). The largest single position, PPTA, represented 29.2% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
AM6
市值: $468.5K
Top Position Liquidated / Trimmed
SOLS
前期市值: $67.8M
In Q1 2026, Paulson & Co. Inc. made 5 total portfolio adjustments, initiating 1 new buys, adding to 2 positions, trimming 1 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.